BofA analyst Lisa Lewandowski lowered the firm’s price target on Altria Group (MO) to $66 from $72 and keeps a Buy rating on the shares. The firm called Altria’s Q3 performance “mixed,” noting that cigarette sales were in line with expectations, but adding that while cigarette volume declines “eased,” it was driven by value brand Basic, and Marlboro’s volume drop accelerated quarter-over-quarter as consumers traded down. Overall, BofA noted, Altria lost 6.1pts of oral tobacco share. Despite the price target cut, BofA reiterates its Buy rating due to the stock’s “reasonable valuation.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MO:
- Unusually active option classes on open October 30th
- Morning Movers: Alphabet, Eli Lilly rise following quarterly results
- Options Volatility and Implied Earnings Moves Today, October 30, 2025
- Altria Group reports Q3 adjusted EPS $1.45, consensus $1.45
- Altria Group narrows FY25 adjusted EPS view to $5.37-$5.45 from $5.35-$5.45
